JP Patent

JP5479114B2 — 微生物によって媒介される病気の治療のためのプレウロムチリン誘導体

Assigned to ナブリヴァ セラピュティクス アクチエンゲゼルシャフト · Expires 2014-04-23 · 12y expired

What this patent protects

Patent listed against lefamulin-acetate.

Drugs covered by this patent

Patent Metadata

Patent number
JP5479114B2
Jurisdiction
JP
Classification
—
Expires
2014-04-23
Drug substance claim
No
Drug product claim
No
Assignee
ナブリヴァ セラピュティクス アクチエンゲゼルシャフト
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.